Fresenius Medical Care AG - ADR (FMS) Company Profile & Statistics

Fresenius Medical Care AG - ADR
FMS
(NYSE)
Open
22.16
+0.18 (+0.82%)
in:usd•As of: Nov 22, 2024 15:40 UTC -5
Open
22.00
High
22.22
Low
22.00

About Fresenius Medical Care AG - ADR

CEO

Helen Giza

Headquarters

else-kroener strasse 1

bad homburg, 2m 61352, germany

Auditor

PricewaterhouseCoopers GmbH

Employees

1,358

Share Holders

2,243

Website

www.freseniusmedicalcare.com

Industry

medical or nursing services

Sector

health services

Company Overview

Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..

Fresenius Medical Care AG - ADR Statistics

Valuation Measures

Market Capitalization ²	13B
Enterprise Value	19.50B
Enterprise Value/EBITDA (ttm)	5.51
Price to Earnings Ratio (ttm)	13.31
Price to Book (mrq)	0.80
Price to Sales (ttm)	0.62
Price to Cash (ytd)	4.78

Profitability

Gross Margin (ttm)	25.11%
Operating Margin (ttm)	4.71%
Profit Margin (ttm)	3.42%
Return on Equity (ttm)	6.04%
Return on Invested Capital (ttm)	4.05%
Return on Assets (ttm)	2.69%

Income Statement

Revenue (ttm)	20.87B
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	5.24B
EBITDA (ttm)³	3.54B
Net Income Avi to Common (ttm)	715.20M
Diluted EPS (ttm)	1.21

Share Statistics

Beta (5Y Monthly)	0.91
52-Week Change	16.34%
S&P500 52-Week Change	30.86%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	2.01%
Float ⁴	0.00
% Held by Insiders	N/A
% Held by Institutions	8.25%

Balance Sheet

Total Cash (mrq)	1.88B
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	8.01B
Total Debt/Equity (mrq)	49.23%
Current Ratio (mrq)	1.37%
Quick Ratio (mrq)	1.02%
Book Value Per Share (mrq)	27.72

Cash Flow

Operating Cash Flow Per Share (ytd)	2.91
Free Cash Flow (ytd)	1.21B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Fresenius Medical Care AG - ADR

Trade With A Regulated Broker